A study for a 50 year old man who takes Dulcolax, Lantus - from FDA reports


Summary

32 males aged 50 (±5) who take the same drugs are studied. This is a personalized study for a 50 year old male patient who has Constipation, Diabetic Type 2. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 12, 2017

32 males aged 50 (±5) who take Dulcolax, Lantus are studied.


Number of reports submitted per year:

Dulcolax, Lantus for a 50-year old man.

Information of the patient in this study:

  • Age: 50
  • Gender: male
  • Conditions: Constipation, Diabetic Type 2
  • Drugs taken:
    • Dulcolax (bisacodyl)
    • Lantus (insulin glargine recombinant)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • weakness
  • abscess
  • blood parathyroid hormone increased
  • haemoglobin decreased
  • drug ineffective
  • renal failure chronic
  • nausea
  • chest pain
  • fatigue
  • blood creatinine increased
1 - 6 months:
n/a
6 - 12 months:
  • abscess
  • international normalised ratio increased
  • exostosis
  • blood creatinine increased
  • weakness
  • skin ulcer
  • localised infection
  • post procedural haemorrhage
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • kidney stones
  • breathing difficulty
  • high blood pressure
  • abdominal pain
  • pneumonia
  • chest pain
  • muscle spasms
  • hypotension
  • productive cough
  • gastroesophageal reflux disease

Top conditions involved for these people *:

  • High Blood Pressure (10 people, 31.25%)
  • Multiple Sclerosis (7 people, 21.88%)
  • High Blood Cholesterol (5 people, 15.62%)
  • Pain (4 people, 12.50%)
  • Nephrogenic Anaemia (3 people, 9.38%)

Top co-used drugs for these people *:

  • Aspirin (14 people, 43.75%)
  • Neurontin (11 people, 34.38%)
  • Ambien (9 people, 28.12%)
  • Miralax (8 people, 25.00%)
  • Amitiza (7 people, 21.88%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Dulcolax, Diabetic type 2, Lantus, Constipation

You may be interested in these reviews

More reviews for: Dulcolax, Diabetic type 2, Lantus, Constipation